Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
NIHR Bioresource Rare Diseases, |
RCV000852051 | SCV000899560 | pathogenic | Thrombotic thrombocytopenic purpura | 2019-02-01 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV000059757 | SCV003441473 | pathogenic | not provided | 2023-04-12 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 68805). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 596 of the ADAMTS13 protein (p.Ala596Val). This variant is present in population databases (rs281875299, gnomAD 0.01%). This missense change has been observed in individual(s) with thrombotic thrombocytopenic purpura (PMID: 15009458, 22783805, 28678087, 30312976, 31064749, 32496441). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects ADAMTS13 function (PMID: 17849048, 22783805). For these reasons, this variant has been classified as Pathogenic. |
Uni |
RCV000059757 | SCV000091327 | not provided | not provided | no assertion provided | not provided |